Key result
Dilated cardiomyopathy incidence reaches ~7 per 100,000 annually, with most cases discovered at autopsy.
Why the study?
Data on the incidence and prevalence of dilated cardiomyopathy are ambiguous due to geographic variations, patient selection, and diagnostic criteria.
Observational (n=5,252)
No
Answers are grounded in this paper and cite their sources.
Dilated cardiomyopathy has a higher incidence in Europe than previously suggested, highlighting the need for greater diagnostic sensitivity.
UNLABELLED: Dilated cardiomyopathy is a heart muscle disease of unknown aetiology, characterized by left ventricular dilatation and impaired systolic function. Data on the incidence and prevalence of the disease is ambiguous, due to geographic variations, patient selection and the diagnostic criteria adopted. METHODS: All the post-mortem and clinical cases observed in a consecutive series of 5252 patients resident in Trieste during the period November 1987-November 1989 were studied. RESULTS: Incidence of the disease discovered at autopsy was estimated at 4.5/100,000/year (24 cases), while clinical incidence in the same period was 2.45/100,000/year (13 cases). This is a total incidence of 6.95/100,000 new cases a year. A possible family history of heart muscle disease was found in three patients (12.5%). In 15 patients (62.5%) deaths were due to cardiological complications. Endocardial thickening (P = 0.03), fatty infiltration (P = 0.01) and arterial involvement (P = 0.04) were found more frequently in older patients (> 65 years). CONCLUSIONS: The study confirms that dilated cardiomyopathy in Europe has a higher incidence than previously suggested and emphasizes the need for greater diagnostic sensitivity, particularly since pharmacological treatment is now so effective.
No takes yet. Share an insight, caveat, or question.
Rakar et al. (1997) conducted an observational in Dilated cardiomyopathy (n=5,252). Resident in Trieste was evaluated on Incidence of dilated cardiomyopathy. The total incidence of dilated cardiomyopathy was 6.95 per 100,000 new cases a year, comprising 4.5 per 100,000 discovered at autopsy and 2.45 per 100,000 identified clinically.
Synapse has enriched 10 related papers. Consider them for comparative context: